Demand Surge in the Breast Cancer Core Needle Biopsy Market amid Rising Cancer Cases

The breast cancer core needle biopsy market is undergoing a transformative phase, driven by the rising global burden of breast cancer and the increasing demand for accurate, minimally invasive diagnostic techniques. According to recent data, the market size was valued at USD 809.40 million in 2023 and is projected to reach USD 1,357.70 million by 2032, expanding at a CAGR of 8.32% from 2024 to 2032. This substantial growth highlights the critical role of advanced diagnostic methods, including image-guided core needle biopsy (CNB) devices, in ensuring early cancer detection and better patient outcomes.
Key Market Trends: Get Your Sample Report! https://www.snsinsider.com/sample-request/6336
Key Drivers & Restraint in the Breast Cancer Core Needle Biopsy Market
The breast cancer core needle biopsy market is primarily fueled by the growing incidence of breast cancer worldwide, which significantly in